Coherus Oncology (CHRS) EBITDA (2013 - 2026)
Coherus Oncology (CHRS) posted EBITDA of -$31.47 million for Q2 2026, compared with -$44.47 million a year earlier.
Powered by 
Analysis
Coherus Oncology (CHRS) EBITDA (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Coherus Oncology was -$155.09 million; for FY2025, it was -$177.21 million.
- In prior years, Coherus Oncology's EBITDA was -$194.38 million in FY2024, -$199.41 million in FY2023, -$253.18 million in FY2022 and -$260.4 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly EBITDA since Q3 2023.
- According to Business Quant data, EBITDA for the three prior quarters was -$35.27 million (Q1 2026), -$44.98 million (Q4 2025) and -$43.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | -31.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.47 Mn |
| Mar 31, 2026 | -35.27 Mn |
| Dec 31, 2025 | -44.98 Mn |
| Sep 30, 2025 | -43.37 Mn |
| Jun 30, 2025 | -44.47 Mn |
| Mar 31, 2025 | -44.39 Mn |
| Dec 31, 2024 | -44.35 Mn |
| Sep 30, 2024 | -45.31 Mn |
| Jun 30, 2024 | -38.44 Mn |
| Mar 31, 2024 | -66.28 Mn |
| Dec 31, 2023 | -67.25 Mn |
| Sep 30, 2023 | -30.52 Mn |
| Jun 30, 2023 | -33.09 Mn |
| Mar 31, 2023 | -66.14 Mn |
| Dec 31, 2022 | -49.64 Mn |
| Sep 30, 2022 | -78.60 Mn |
| Jun 30, 2022 | -42.13 Mn |
| Mar 31, 2022 | -76.46 Mn |
| Dec 31, 2021 | -37.60 Mn |
| Sep 30, 2021 | -30.80 Mn |
API Access
Coherus Oncology EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();